More from Curaleaf

Curaleaf International Partners with UK Task Force to Lead Cannabis Research Revolution

Curaleaf International is proud to announce its official partnership as a founding member of a groundbreaking task force aimed at positioning the UK as a global leader in cannabis and cannabinoid research.

This pioneering initiative, led by George Freeman MP and Professor Trevor Jones, will unite universities, research institutions, investors, businesses, and the NHS to advance the understanding of cannabis.

The newly established UK Cannabinoid Research and Development Group (CRDG) is set to develop the country’s first comprehensive cannabinoid R&D strategy, addressing a significant gap that has persisted since cannabis was rescheduled for medical use in 2018. Notably, the UK currently has only three licensed cannabis-based medicines available.

With support from industry partners, including Curaleaf International, the task force will consult on its plans and release its initial strategy paper in July. The group will be officially constituted this summer.

Find out more at crdg.uk

UK Cannabinoid Research and Development Group

Latest News

24/05/2024

Eligible patients in Sweden can now access medical cannabis through Sapphire Clinics. The clinic …

19/04/2024

An opinion article from Dr Simon Erridge, Research Director Curaleaf Clinic New research from …

21/03/2024

Curaleaf International, a market-leading global cannabis company, has been announced as the Headline Partner …

You are about to leave the Curaleaf International website.